Asif Ali

Chief Financial Officer

Asif Ali (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $3.8M of PTGX (46,203 sh across 2 lots, as filed), executed Jan 27.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$7.3M

shares × price, as filed

Last traded

Apr 20

Filed Apr 21

Median ADV $107.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $8.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

PTGX

Protagonist Therapeutics, Inc. PTGX · 0 buys · 5 sells 5 filings

Recent filings

PTGXSALE Protagonist Therapeutics, Inc. View filing → $185K
1,750 sh × $105.47
Exec Apr 20
Filed Apr 21 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $2.6M
24,765 sh × $104.24
Exec Mar 26
Filed Mar 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $3.8M
46,203 sh across 2 lots
Exec Jan 27
Filed Jan 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $708K
8,588 sh × $82.48
Exec Jan 20
Filed Jan 21 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $1.5M
24,903 sh × $58.73
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $534K
12,000 sh × $44.47
Exec Sep 11 2024
Filed Sep 13 2024 · 5:30 PM ET